(Q58949457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

chronic renal insufficiency

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Carmine Zoccali

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

K Caglar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M I Yilmaz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

E Cakir

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

A Kaya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

C Acikel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

T Eyileten

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M Yenicesu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Y Oguz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

C Bilgi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

C Oktenli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

A Vural

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

5 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

781-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Proteinuria is a prognostic marker for cardiovascular mortality: NIPPON DATA 80, 1980-1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Vascular function of the peripheral circulation in patients with nephrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Does ADMA cause endothelial dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Microalbuminuria, cardiovascular, and renal risk in primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Endothelial dysfunction: a marker of atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Endothelial dysfunction and inflammation in asymptomatic proteinuria.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Hypercholesterolemia impairs basal nitric oxide synthase turnover rate: a study investigating the conversion of L-[guanidino-(15)N(2)]-arginine to (15)N-labeled nitrate by gas chromatography--mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Cellular responses to protein overload: key event in renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001632

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16820789%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference